Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 6, 2007, Pages 927-932

  Ishola, Titilope A ^a   Kang, JungHee ^a   Qiao, Jingbo ^a   Evers, B Mark ^a,b   Chung, Dai H ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Akt; Bombesin; Cell cycle; GRP; Neuroblastoma; PI3K

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BOMBESIN; G PROTEIN COUPLED RECEPTOR; GASTRIN ANTAGONIST; GASTRIN RELEASING PEPTIDE; GRPH 2756; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AUTOCRINE COMMUNICATION; BOMBESIN; CELL LINE, TUMOR; CHROMONES; ENZYME INHIBITORS; G1 PHASE; GASTRIN-RELEASING PEPTIDE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MORPHOLINES; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTORS, BOMBESIN; RNA, SMALL INTERFERING; S PHASE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 34247248710     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.02.002     Document Type: Article

References (20)

1. van Noesel M.M., and Versteeg R. Pediatric neuroblastomas: genetic and epigenetic 'danse macabre'. Gene 325 (2004) 1-15
2. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 3 (2003) 203-216
3. Schwab M., Westermann F., Hero B., and Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol. 4 (2003) 472-480
4. Hennessy B.T., Smith D.L., Ram P.T., Lu Y., and Mills G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev., Drug Discov. 4 (2005) 988-1004
5. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
6. Liang J., and Slingerland J.M. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 2 (2003) 339-345
7. Qiao J., Kang J., Cree J., Evers B.M., and Chung D.H. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas. Ann. Surg. 241 (2005) 684-691
8. Maris J.M., and Matthay K.K. Molecular biology of neuroblastoma. J. Clin. Oncol. 17 (1999) 2264-2279
9. Gustafson W.C., De Berry B.B., Evers B.M., and Chung D.H. Role of gastrointestinal hormones in neuroblastoma. World J. Surg. 29 (2005) 281-286
10. Kim S., Hu W., Kelly D.R., Hellmich M.R., Evers B.M., and Chung D.H. Gastrin-releasing peptide is a growth factor for human neuroblastomas. Ann. Surg. 235 (2002) 621-629 (discussion 629-630)
11. Carr J., Bell E., Pearson A.D., Kees U.R., Beris H., Lunec J., and Tweddle D.A. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse. Cancer Res. 66 (2006) 2138-2145
12. Wallick C.J., Gamper I., Thorne M., Feith D.J., Takasaki K.Y., Wilson S.M., Seki J.A., Pegg A.E., Byus C.V., and Bachmann A.S. Key role for p27Kip1, retinoblastoma protein Rb, and MYCN in polyamine inhibitor-induced G1 cell cycle arrest in MYCN-amplified human neuroblastoma cells. Oncogene 24 (2005) 5606-5618
13. Liu G., and Lozano G. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell 7 (2005) 113-114
14. Yu J., and Zhang L. The transcriptional targets of p53 in apoptosis control. Biochem. Biophys. Res. Commun. 331 (2005) 851-858
15. Sorrentino G., Singh I.N., Massarelli R., and Kanfer J.N. Stimulation of phospholipase C activity by norepinephrine, t-ACPD and bombesin in LA-N-2 cells. Eur. J. Pharmacol. 308 (1996) 81-86
16. Okkenhaug K., and Vanhaesebroeck B. PI3K in lymphocyte development, differentiation and activation. Nat. Rev., Immunol. 3 (2003) 317-330
17. Lui V.W., Thomas S.M., Zhang Q., Wentzel A.L., Siegfried J.M., Li J.Y., and Grandis J.R. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Oncogene 22 (2003) 6183-6193
18. Sumitomo M., Milowsky M.I., Shen R., Navarro D., Dai J., Asano T., Hayakawa M., and Nanus D.M. Neutral endopeptidase inhibits neuropeptide-mediated transactivation of the insulin-like growth factor receptor-Akt cell survival pathway. Cancer Res. 61 (2001) 3294-3298
19. Ho R., Minturn J.E., Hishiki T., Zhao H., Wang Q., Cnaan A., Maris J., Evans A.E., and Brodeur G.M. Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res. 65 (2005) 9868-9875
20. Leventhal P.S., Randolph A.E., Vesbit T.E., Schenone A., Windebank A., and Feldman E.L. Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp. Cell Res. 221 (1995) 179-186